APTO

Aptose Biosciences, Inc.
APTO

Overview Fund Activity
Delisted

APTO was delisted on the 1st of April, 2025.

Back to rankings

30 hedge funds and large institutions have $31.1M invested in Aptose Biosciences, Inc. in 2019 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
+8
Holders Change %
+36.36%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
10
Reduced
3
Closed
4
Calls
$5K
Puts
$130K
Net Calls
-$125K
Net Calls Change
-$175K

Top Buyers

1
NCM
Nantahala Capital Management
Connecticut
$8.91M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
$5.74M
3
Man Group
Man Group
United Kingdom
$3.87M
4
DS
DRW Securities
Illinois
$8.74M
5
SMH
Sanders Morris Harris
Texas
$572K

Top Sellers

1
VF
Virtu Financial
New York
$94K
2
Citadel Advisors
Citadel Advisors
Florida
$0
3
NFG
Noven Financial Group
Colorado
$0
4
Jane Street
Jane Street
New York
$0
5
TSS
Two Sigma Securities
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Deutsche Bank
26
Deutsche Bank
Germany
$7K -$3.5K -3 -33%
FDCDDQ
27
Federation des caisses Desjardins du Quebec
Quebec, Canada
$4.54K – – –
GCM
28
Gables Capital Management
Florida
$3K – – –
TRCT
29
Tower Research Capital (TRC)
New York
$2K +$2K +2 New
CSS
30
Cubist Systematic Strategies
Connecticut
$1K +$1K +1 New
Citadel Advisors
31
Citadel Advisors
Florida
– -$66K -73 Closed
NFG
32
Noven Financial Group
Colorado
– -$37K -41 Closed
Jane Street
33
Jane Street
New York
– -$35K -39 Closed
TSS
34
Two Sigma Securities
New York
– -$25K -28 Closed
1
2